TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics
AMGN•Amgen to terminate collaboration agreement
Aug. 18 (Reuters) - Amgen Inc. (AMGN.O):
- TScan Therapeutics - Amgen to terminate research collaboration and license agreement with TScan Therapeutics - SEC filing
- TScan Therapeutics - termination of collaboration agreement effective November 10, 2026 - SEC filing
Source text: [ID:n0001193125-26-355664]
Further company coverage: AMGN.O
